Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26615328

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Feb 6
First author
Wang-Gillam A

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Feb 6;387(10018):507-508. doi: 10.1016/S0140-6736(15)01035-1.
    note
    Source null
    related pmid
    26616909
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 Jan;13(1):2-3. doi: 10.1038/nrclinonc.2015.220.
    note
    Source null
    related pmid
    26667974
    relationship
    Comment in
  3. citation
    Lancet. 2016 Feb 6;387(10018):536. doi: 10.1016/S0140-6736(15)01306-9.
    note
    Source null
    related pmid
    26867448
    relationship
    Erratum in
  4. citation
    Nat Rev Clin Oncol. 2016 Apr;13(4):205-6. doi: 10.1038/nrclinonc.2016.22.
    note
    Source null
    related pmid
    26902963
    relationship
    Comment in
  5. citation
    Lancet. 2016 May 14;387(10032):1997. doi: 10.1016/S0140-6736(16)30365-8.
    note
    Source null
    related pmid
    27203770
    relationship
    Comment in
  6. citation
    Lancet. 2016 May 14;387(10032):1997. doi: 10.1016/S0140-6736(16)30463-9.
    note
    Source null
    related pmid
    27203772
    relationship
    Comment in

Authors and identifiers

  1. name
    Wang-Gillam A
    type
    Author
  2. name
    Li CP
    type
    Author
  3. name
    Bodoky G
    type
    Author
  4. name
    Dean A
    type
    Author
  5. name
    Shan YS
    type
    Author
  6. name
    Jameson G
    type
    Author
  7. name
    Macarulla T
    type
    Author
  8. name
    Lee KH
    type
    Author
  9. name
    Cunningham D
    type
    Author
  10. name
    Blanc JF
    type
    Author
  11. name
    Hubner RA
    type
    Author
  12. name
    Chiu CF
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wang-Gillam A
    type
    Author
  2. name
    Li CP
    type
    Author
  3. name
    Bodoky G
    type
    Author
  4. name
    Dean A
    type
    Author
  5. name
    Shan YS
    type
    Author
  6. name
    Jameson G
    type
    Author
  7. name
    Macarulla T
    type
    Author
  8. name
    Lee KH
    type
    Author
  9. name
    Cunningham D
    type
    Author
  10. name
    Blanc JF
    type
    Author
  11. name
    Hubner RA
    type
    Author
  12. name
    Chiu CF
    type
    Author
bibliography ids
  1. nci-bib-aa0bbce60f37f6466446ed8c
book metadata
content sha256
406c9fa8b80861bd5348e8665d1d0f68b3a13d27b73250d165dfee1109adb1e6
document type
citation
dois
  1. 10.1016/S0140-6736(15)00986-1
electronic publication date
display
2015 Nov 29
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26615328
immutable id
pubmed:26615328@406c9fa8b80861bd5348e8665d1d0f68b3a13d27b73250d165dfee1109adb1e6
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10018
name
Lancet (London, England)
nlm unique id
2985213R
pages
545-557
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Feb 6;387(10018):507-508. doi: 10.1016/S0140-6736(15)01035-1.
    note
    Source null
    related pmid
    26616909
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 Jan;13(1):2-3. doi: 10.1038/nrclinonc.2015.220.
    note
    Source null
    related pmid
    26667974
    relationship
    Comment in
  3. citation
    Lancet. 2016 Feb 6;387(10018):536. doi: 10.1016/S0140-6736(15)01306-9.
    note
    Source null
    related pmid
    26867448
    relationship
    Erratum in
  4. citation
    Nat Rev Clin Oncol. 2016 Apr;13(4):205-6. doi: 10.1038/nrclinonc.2016.22.
    note
    Source null
    related pmid
    26902963
    relationship
    Comment in
  5. citation
    Lancet. 2016 May 14;387(10032):1997. doi: 10.1016/S0140-6736(16)30365-8.
    note
    Source null
    related pmid
    27203770
    relationship
    Comment in
  6. citation
    Lancet. 2016 May 14;387(10032):1997. doi: 10.1016/S0140-6736(16)30463-9.
    note
    Source null
    related pmid
    27203772
    relationship
    Comment in
outcomes validated
false
pmid
26615328
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
ea84f3e4f0ebee1b89dd07bd14aabccefc0e7e4fe80aad4f4e9a792d9d6edc63
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Feb 6
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26615328/
title
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

Preserved source evidence · Not medical advice